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Complaints of taste and smell dysfunction unaccompanied by symptoms of neurological or
nasal problems are not uncommon. However, "I can't taste" is not necessarily an accurate
symptom description. Complaints tend to reflect the common confusion between taste sensations
(that is, salt, sour, sweet, bitter) and flavor sensations (including taste, smell, temperature, and
texture). A number ofquestions have been identified that help classify symptoms according to the
typeofdysfunction (taste, smell, or both): whether the problem is quantitative (reduced or absent
sensation) or qualitative (distorted sensations); and what might have caused the dysfunction.
Directed questioning can yield a clinical history that predicts chemosensory function and
identifies the most likely cause of the problem. Questions were assessed by comparing the
self-reports of taste and smell symptoms to the clinical evaluation of chemosensory function for
101 new patients seen in the Taste and Smell Center at the University of Connecticut Health
Center in 1983.
Taste and smell complaints unaccompanied by obvious signs or symptoms of
neurological or nasal problems are not uncommon [1,2]. Unfortunately, there is no
validated set of questions to use to obtain a clinical history of taste and smell
symptoms. Standard texts on physical diagnosis usually suggest a line of questioning
for patients with chemosensory complaints, but specific questions designed to predict
probable cause are not provided [3,4]. Therefore, we were interested in validating the
questions we use to obtain the clinical history of our patients' taste and smell
symptoms. Judging by the inquiries received over the past few years from a variety of
health care professionals, such a validated set ofquestions could be useful additions to
health assessment surveys in the areas of environmental health [5] and occupational
medicine, as well as various projects involving special clinical populations (for
example, elderly denture wearers, hospitalized psychiatric patients, and the like).
Patients presenting to the Taste and Smell Center at the University of Connecticut
Health Center are primarily self-referred and have a chemosensory problem as the
chief complaint. Questions used for obtaining a clinical history of a chemosensory
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problem, such as reduced smell function (hyposmia) or distorted taste sensations
(dysgeusia), were developed during the first two years of patient evaluations, 1981-82.
In order to assess validity in indicating clinically measured taste and smell function and
utility in predicting the probable cause of the symptoms, responses to questions about
taste and smell symptoms were compared to the clinical evaluations for 101 patients
seen in 1983. We report here the results of our assessment ofhow well patient responses
to questions about taste and smell symptoms predict clinically measured taste and
smell function. We also report which questions have the greatest predictive value as
indicators of the four most common causes of chemosensory symptoms as a chief
complaint: nasal or sinus disease, post viral-like upper respiratory infection, head
trauma, and idiopathic sensory loss [1,2].
METHODS
The list of questions under study was included in a self-administered registration
survey sent to all prospective patients. The study group (N = 101) consisted of all
patients who were evaluated at the Taste and Smell Center in 1983 who had also
completed the same version of the registration survey. Data from each study patient's
registration survey were coded and combined with selected information from the
clinical evaluation [1]. Clinical variables included taste and smell function diagnoses
and the clinically determined probable cause of the dysfunction.
Quantitative smell and taste function were assessed using tests developed at the
Taste and Smell Center [6,7,8]. The smell test consists of two parts: a threshold test for
absolute sensitivity to butyl alcohol, and a ten-item odor identification test. The
threshold test is a two-alternative, forced-choice task; starting with the weakest, a
dilution series of butyl alcohol is paired with a water blank. Stimulus pairs are
presented in plastic squeeze bottles to one nostril at a time. The patient's task is to
select the bottle with the "smell." The threshold is that dilution step where the patient
is able to choose correctly the bottle with the butyl alcohol four trials in a row. The odor
identification task is also administered to one nostril at a time. On each trial a patient is
asked to close his or her eyes, sniff the stimulus presented in an opaque plastic jar, then
say what the item is. The patient is given a list of 20 odor names (including the ten test
items plus ten other odors not on the test) from which to select the answer. The patient
is given corrective feedback after each trial. Each item is presented twice to each
nostril. A composite smell function score is calculated, based on the performance scores
on each test [6,8].
The taste test consists of a sip-and-spit task of quality identification and intensity
rating of several concentration levels of sodium chloride, sucrose, citric acid, and
quinine hydrochloride. Patients are also asked to rate the loudness of several decibel
levels of a 1,000 Hz tone. For patients with no known hearing problems, the inclusion
of tones permits a comparison between a patient's perception of taste and auditory
sensations. Based on data from normal control subjects [8], the loudness of tones (from
soft to loud) roughly matches the intensity of the solution concentrations (from weak to
strong). A taste function score is calculated based on the intensity ratings given to the
strongest solutions and the loudest tones [7,8].
The clinical evaluation of parosmia (odor quality distortions or phantom odors) and
dysgeusia (taste quality distortions) is based on the patient's responses to a structured
interview administered by a trained staff member at the time of the clinic visit. It
includes an assessment of the recency in onset of the problem: the frequency, duration,
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and severity ofoccurrences; and the most recent occurrence. A patient is considered to
have parosmia or dysgeusia if, in the opinion of the interviewer, the patient is able to
describe the problem in some detail and has had a recent (within six months)
occurrence.
Clinically assigned probable cause is based on the medical findings (for example,
X-ray results) and the history taken at the time ofthe patient's visit [1].
Associations between self-report and clinic assessment were examined using two-
by-two contingency table analyses (X2 or Fisher's exact tests, p < 0.05; Statistical
Analysis System [SAS]). For this purpose, self-reports were transformed into dichoto-
mous variables and compared to the presence or absence of a particular clinical
characteristic. Self-reported smell function (normal or abnormal), for example, was
compared to clinically diagnosed nasal/sinus disease (present or absent). These
analyses identified a subset of questions significantly associated with clinical
outcomes.
Test characteristics (sensitivity, specificity, predictive values) were calculated for
this subset of questions. A Bayesian approach (that is, conditional probability) was
used to evaluate the usefulness of a particular question or sequence of questions.
Conditional probability analysis has been used previously to help determine the
predictive value of a symptom (such as chest pain) as an indicator of a particular
disease (for example, coronary artery disease) [9,10].
RESULTS
The 101 patients in the study included 59 males and 42 females ranging in age from
10 to 76 years with an average age of 49.4 years. Nearly half (45.6 percent) of the
patients in this study group reported having had a taste or smell problem for less than
one year; 24.0 percent for one to three years; 10.1 percent for three to five years; 11.4
percent for five to ten years; and 8.9 percent for over ten years.
The clinical assessment ofquantitative olfactory function showed that 90 percent of
the patients had abnormal function: 47 percent of these 101 patients had no sense of
smell (anosmia), 43 percent had reduced olfactory sensitivity (hyposmia). The
remaining 10 percent were normosmic. Results of the clinical assessment of taste
functionsuggested that noneofthe 101 patients wasageusic (taste functionabsent); 32
percent appeared to have somewhat reduced sensitivity, and 68 percent had normal
taste function.
Clinical assessment ofquality distortions suggested that 13.9 percentofthe patients
probably had parosmia, an equal number appeared to have a dysgeusia, and 5.9
percent appeared to suffer from both. The clinical impression agreed with 15 out of48
(31 percent) ofthe patients' self-reports thatparosmia was present and 48 outof53 (91
percent) ofthe reports that parosmia was absent. The clinical impression agreed with
14 out of 35 (40 percent) of the patients who reported dysgeusia present and 60 out of
66 (91 percent) who reported dysgeusia absent.
The clinically determined likely causes of the chemosensory problem for these 101
patients were nasal or sinus disease such as nasal polyposis, chronic sinusitis, allergic
rhinitis (32.7 percent); post viral-like upper respiratory infection-that is, a history of
flu-like illness immediately prior to thechemosensory loss (17.8 percent); head trauma
(11.9 percent); and miscellaneous causes-for example, cranial surgery, dental
problems, toxic exposures (8.9 percent). Of the remaining patients, 5.9 percent had
multiple probable causes, and in 22.8 percent the cause was unknown.
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Table 1 lists the test characteristics for questions used to screen for quantitative
taste and smell function as measured by the clinical tests. The sensitivity and
specificity ofeach question werecalculated from thesampledata. Predictive values are
given for three different taste or smell dysfunction prevalence values. Prevalence of
olfactory dysfunction at our Taste and Smell Center is high;.O.90 for the study group
TABLE 1
Screening Questions for Quantitative Chemosensory Function: Test Characteristics and
Predictive Values'
Test Characteristicsb Predictive Valuesc
Chemosensory
Dysfunction SENS SPEC ERR PREVd PV+ PV-
Smell
1. Do you have trouble smelling? (N = 93)




1. Do you have trouble tasting? (N = 70)
0.79 0.13 0.64 0.10 0.09 0.85
0.30 0.28 0.59
0.90 0.89 0.06
2. Do you have trouble tasting salt, sweet, sour, bitter?' (N = 80)
0.60 0.74 0.30 0.10 0.20 0.94
0.30 0.50 0.81
0.90 0.95 0.17
'Calculations based on data from Npatients (given after each question)
bTest characteristics:
SENS = Sensitivity = True Positives (TP)/[TP + False Negatives (FN)]
SPEC = Specificity c True Negatives (TN)/[TN + False Positives (FP)]
ERR = Error Rate = (FP + FN)/Population
cPredictive values:
PV+ = Positive Predictive Value
= Probability (p) ofdisease present (DIS+) given a positive response (R+); that is,
p(DIS+/R+)




(PREV)(SENS) + (1 - PREV)(1 - SPEC)
PV - = Negative Predictive Value
= Probability (p) ofdisease absent (DIS-) given a negative response (R-); that is,
p(DIS-/R-)
(1 - PREV)(SPEC)
(1 - PREV)(SPEC) + (PREV)(1 - SENS)
dPREV = Prevalence ofdisease (for example, chemosensory dysfunction)
'Patients wereasked to rate each tastequality (salt, sweet, sour, bitter) on a four-point scale: (1) as strong,
(2) less strong, (3) very weak, (4) no taste, as compared to its taste before the problem began. The sum of
responses could range from a minimum of 4 (all tasted "as strong") to a maximum of 16 (all had "no
taste"). A sum >8, that is, at least one of the qualities tasted "very weak," was considered a positive
response to the question; <8 was considered negative. This breakpoint of 8 produced a significant
x2(= 6.79, df = 1, Fisher's exactp < 0.01) when compared to clinical taste function test results.
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TABLE 2
Screening Questions for Nasal/Sinus Disease (NSD) or Post-Upper Respiratory Infection (URI) as
Probable Cause of the Chemosensory Problem: Test Characteristics and Predictive Valuesa
Test Characteristics Predictive Values
Probable
Question Cause SENS SPEC ERR PREV PV+ PV-
1. Do you have trouble smelling?b (N = 93)
NSD 1.0 0.18 0.53 0.05 0.06 1.0
0.20 0.23 1.0
0.30 0.34 1.0
URI 1.0 0.14 0.72 0.05 0.06 1.0
0.20 0.22 1.0
0.30 0.33 1.0
2. Does smell sensitivity fluctuate?' (N = 84)
NSD 0.59 0.67 0.36 0.05 0.09 0.97
0.20 0.31 0.87
0.30 0.43 0.79
URI 0.33 0.55 0.49 0.05 (0.06) (0.96)
0.20 (0.23) (0.84)
0.30 (0.34) (0.76)
3. Do you have trouble tasting salt, sweet, sour, bitter?' (N = 81)
NSD 0.31 0.62 0.49 0.05 (0.06) (0.96)
0.20 (0.22) (0.83)
0.30 (0.32) (0.74)
URI 0.69 0.71 0.30 0.05 0.11 0.98
0.20 0.37 0.90
0.30 0.50 0.84
aRefer to footnotes ofTable 1 for definitions ofTest Characteristics, PREV, and Predictive Values.
bAll patients in the study group who weresubsequentlydiagnosed as having NSD orpost-URI entered the
clinic complaining of a smell problem. As a result, test sensitivity and negative predictive value equal
1.0.
CPredictive values in parentheses (PV+ and PV-) are based on negative and positive responses,
respectively; that is, for this question PV+ = p(DIS+/R-) and PV- = p(DIS-/R+).
(included in Table 1) and 0.85 for our clinic population [1]. Prevalence oftaste deficits
is 0.34 for the study group and 0.32 for our clinic population.
Table 2 lists test characteristics for three questions that were particularly useful in
screening for the top two causes of chemosensory dysfunction: nasal/sinus disease
(NSD) and post viral-like upper respiratory infection (URI). Again, sensitivity and
specificity were based on the sample data, and predictive values are given for three
different disease prevalence values.
Tables 3 and 4 illustrate the use of responses to three screening questions asked in
sequence to estimate the likelihood ofNSD (Table 3) or URI (Table 4) as the cause of
the chemosensory problem.
DISCUSSION
It seems that a good way to screen for olfactory deficit is simply to ask patients to
describe their ability to smell. The sensitivity of such a direct question is high (0.95)
and suggests that, in general, nearly all patients (95 percent) who score in the
abnormal range on an olfactory function test will self-report a loss of olfactory
function. The specificity (0.64) suggests that although most ofthe patients who do not
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TABLE 3
Using Responses in Sequence to Estimate the Likelihood of Nasal/Sinus Disease (NSD) in a Patient
Presenting to the Taste and Smell Centera
(Prevalence of NSD = 0.30)
NO. YES; PV+ =0.34
NSD very unlikely. Further GOTO Q2.
questions screening for NSD
are unnecessary. END
NO; PV-= 0.76; PV+ = 0.24 YES; PV+ = 0.48
GO TO Q3. GOTOQ3.
Q3: Doyou have trouble tastingsalt, sweet, sour, bitter?
NSD cannot be NSD unlikely in NSD most likely NSD cannot be
ruled out. this patient. in this patient. ruled out.
Screen for other Examine for signs
causes. and symptoms.
aRefer toc,Table 1 fordefinitionsofPV+ and PV -. Notethattheprevalenceofdisease is "revised" after
each response in the questioning sequence. For example, the initial prevalence ofNSD is 0.30 and is used
to estimate the PV+ after Ql. This revised prevalence (0.34) becomes the disease prevalence value for
estimating the PV+ ofQ2.
complain of smell function loss will score in the normal range, some will score in the
abnormal range. One might expect the positive predictive value of such a direct
question to be high (0.96 for our patients; refer to Table 1) in a population where the
prevalence ofolfactory deficit is high. But the predictive values (positive and negative)
are greater than the prevalence of disease (present and absent) for a wide range of
prevalence figures (Table 1). This result suggests that direct questioning about
olfactory function is a valid way to screen for olfactory dysfunction in many different
clinical settings.
The specificity of this question is perhaps partially a function of the age of the
population tested. It should be noted that, in our sample, all ofthe patients who did not
complain of olfactory function loss yet scored in the abnormal range (4 out of 11
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TABLE 4
Using Responses in Sequence to Estimate the Likelihood of Post Viral-like Upper Respiratory
Infection (URI) in a Patient Presenting to the Taste and Smell Center'
(Prevalence of URI = 0.19)
(Q: Doyou have trouble smelling?
NO. YES; PV+ = 0.21
URI very unlikely. GOTO Q2.
f d2: Does smellsensitivityfluctuate?
NO; PV+ = 0. l YES; PVb-= 0.84; PV+ n 0.16
GO TO Q3. URI unlikely, but
GOTO Q3.
Q3: Doyou have trouble tastingsalt, sweet, sour, bitt
NO; PV-=08_ YES; PV+ = 0.43 NO; PV- = 0.92 YES; PV+ =0.31
URI unlikely. URI likely. URI unlikely. URI cannot be
Screen for Continue to Screen for ruled out.
Other causes. take history. other causes.
aRefer to a, Table 3.
non-complainers) were over the age of 55. There is evidence to suggest that olfactory
function declines gradually with age [1I1,12,13]. It is possible that for many people the
loss of olfactory function is too gradual to be bothersome or even noticeable. The
application ofage-corrected norms to olfactory function tests would probably improve
the specificity ofthis question somewhat.
It may seem obvious that a patient's response to a direct question concerning the
ability to taste or smell would be a highly accurate way to screen for chemosensory
dysfunction. We have confirmed this assumption for the sense of smell. However, the
specificity of a similarly straightforward question about taste function is poor (0.13)
and the overall error rate is high (0.64) (refer to Table 1). For example, 87 percent of
those who report a tasteproblem in fact have no measurable tastedeficit (false-positive
rate). Patients appear to overreport taste problems because of the common use of the
word taste to mean flavor. Flavor perception comprises olfactory, tactile, and thermal,
as well as taste, sensations. Thus, it is difficult to interpret loss of taste as a chief
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complaint since the patient could be referring to any of the component sensations of
flavor.
A more useful way to screen for actual loss of taste function is to ask about the
ability to perceive the four taste qualities. When the self-report on each ofthe qualities
is pooled (refer to e, Table 1), the sensitivity and specificity of this question are good
(0.60 and 0.75, respectively). The positive and negative predictive values are greater
than the prevalence oftaste dysfunction for a range ofprevalence values.
The assessment of a patient's qualitative chemosensory complaint (parosmia or
dysgeusia) will become more reliable as objective criteria take the place of subjective
impressions. Meanwhile, our impressions to date suggest that patients tend to
overreport qualitative chemosensory problems. It appears that responses to questions
concerning quality distortions are best used to rule out a problem: for example, quality
distortion questions had high values (0.86 to 0.91) for predicting the absence ofquality
distortion problems among our patients.
The probable causes of the chemosensory problems identified in the study popula-
tion (see Results) are representative ofthose found in the larger population ofpatients
seen at the Taste and Smell Center [1]. Table 2 lists the test characteristics for three
questions used to screen for the two most common specific causes: nasal/sinus disease
(NSD) and post viral-like upper respiratory infection (URI). Positive and negative
predictive values are also given for several disease prevalence values. The sensitivity of
the first question ("Do you have trouble smelling?"), is "perfect" since all of the
patients in the study group who weresubsequently diagnosed with thedisease (NSD or
post-URI) had entered the clinic complaining ofa smell problem. As a result, all ofthe
estimates for the negative predictive values are also "perfect"; that is, if the patient
does not complain of a smell problem, the probability that the disease is absent is 1.0.
However, the question should not be dismissed as worthless for use outside a Taste and
Smell Clinic. As can be seen in Table 2, the likelihood of disease in the presence of a
smell problem (positive predictivevalue) is greater than the prevalence ofdisease for a
range ofprevalence values.
A positive response to the second question listed ("Does smell sensitivity
fluctuate?"), increases the likelihood that the patient has NSD, while a negative
response increases the likelihood that post-URI is the cause (refer to c, Table 2). It
appears that among patients suffering from nasal/sinus disease, a temporary return of
smell function occurs occasionally. This experience is rarely reported by those whose
smell problem is caused by post-URI.
Taste abnormalities have been associated previously with post-URI [1,14]. As may
be seen in Table 2, the sensitivity and specificity of question 3 ("Do you have trouble
tasting salt, sweet, sour, bitter?"), are high when it is used to screen for URI. Also
interesting is that a positive response to this question approximately doubles the
likelihood of disease for each of the prevalence values given. When used to screen for
NSD, a negative response is the best predictor ofpresence ofdisease (refer to c, Table
2).
Tables 3 and 4 illustrate the use ofresponses to these three questions when asked in
sequence to estimate the likelihood of NSD (Table 3) or post-URI (Table 4) as the
cause of the chemosensory complaint. The flow diagram in each table is for a patient
presenting to the Taste and Smell Center. The prevalence values used are those ofthe
Taste and Smell Center population. Disease prevalence values would no doubt be
different for different clinic situations, and corresponding estimates of likelihood of
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disease can becalculated using the formulas given in a, Table 3. Using this questioning
strategy, and for any value of NSD prevalence, the likelihood of NSD is greatest for
the patient who has a fluctuating problem with smell function and no trouble tasting
salt, sour, sweet, or bitter. For the example given, the likelihood ofNSD was increased
from 0.3.0 to 0.51. Using the same series of questions, the probability of post-URI is
most likely for the patient who has a smell problem that does not fluctuate and who has
trouble tasting salt, sweet, sour, and bitter. In the example given, the probability of
post-URI is increased from 0.19 to 0.43.
It is our feeling that the patients in this study as well as the others who have come to
the Taste and Smell Center are representative of patients who might present to a
clinician with a chief complaint of chemosensory dysfunction. These are not the
patients with signs and symptoms of nasal polyps or neurological problems and
secondary taste and smell complaints, who might present toan ear, noseand throator a
neurology clinic. A patient whose taste or smell problem is the chiefor only complaint
is most likely to have one of four causes of the chemosensory problem: nasal/sinus
disease, post-URI, head trauma, or idiopathic sensory loss.
The use of these questions at the beginning of the medical history can help the
clinician evaluate a patient's taste and smell symptoms, estimate the likelihood of the
probable cause, then appropriately select any subsequent diagnostic tests (for example,
quantitative chemosensory testing, sinus X-rays, or neurologic evaluation).
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